Press Releases

Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack.
Apr 03, 2020
​​​​​ Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced it has been honored with a bronze Edison Award in the category of Medical/Dental Testing Solutions for its VITROS® XT Solutions,
Mar 18, 2020
Recognition is latest for Ortho Care™, Ortho’s award-winning customer service and support program Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, has been named a bronze medal winner at the 14th
Mar 03, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS XT 3400 Chemistry System, which completes the company’s VITROS XT Solutions, a comprehensive
Feb 26, 2020
Ortho Clinical Diagnostics Enters Into a $375 Million Euro-Denominated Term Loan and Issues $675 Million in Senior Notes to Refinance $1 Billion of its $1.3 Billion 6.625 Percent Senior Notes Due in 2022 Ortho Clinical Diagnostics (“Ortho” or the “Company”), a global leader of in vitro diagnostics
Feb 03, 2020
Displaying 31 - 40 of 102